IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
28.13
-0.19 (-0.67%)
May 11, 2026, 4:00 PM EDT - Market closed
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of $2.47 billion as of May 12, 2026. Its market cap has increased by 48.60% in one year.
Market Cap
2.47B
Enterprise Value
1.53B
1-Year Change
48.60%
Ranking
Category
Stock Price
$28.13
Market Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from $215.57M to $2.47B, an increase of 1,046.52%. That is a compound annual growth rate of 41.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 2.47B | -18.45% |
| Dec 31, 2025 | 3.03B | 36.44% |
| Dec 31, 2024 | 2.22B | -3.15% |
| Dec 29, 2023 | 2.29B | 162.34% |
| Dec 30, 2022 | 874.22M | -3.92% |
| Dec 31, 2021 | 909.90M | 123.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vera Therapeutics | 2.63B |
| Immunome | 2.60B |
| Ultragenyx Pharmaceutical | 2.58B |
| Tarsus Pharmaceuticals | 2.57B |
| Celldex Therapeutics | 2.53B |
| Kodiak Sciences | 2.49B |
| Relay Therapeutics | 2.46B |
| Mineralys Therapeutics | 2.45B |